PTP 250 User Guide
Term of license
Your right to use the Software will continue in perpetuity unless terminated as follows.
Your right to use the Software will terminate immediately without notice upon a breach of
this Agreement by you. Within 30 days after termination of this Agreement, you will
certify to Motorola in writing that through your best efforts, and to the best of your
knowledge, the original and all copies, in whole or in part, in any form, of the Software and
all related material and Documentation, have been destroyed, except that, with prior
written consent from Motorola, you may retain one copy for archival or backup purposes.
You may not sublicense, assign or transfer the license or the Product, except as expressly
provided in this Agreement. Any attempt to otherwise sublicense, assign or transfer any of
the rights, duties or obligations hereunder is null and void.
Governing law
This Agreement is governed by the laws of the United States of America to the extent that
they apply and otherwise by the laws of the State of Illinois.
Assignment
This agreement may not be assigned by you without Motorola's prior written consent.
Survival of provisions
The parties agree that where the context of any provision indicates an intent that it
survives the term of this Agreement, then it will survive.
Entire agreement
This agreement contains the parties' entire agreement regarding your use of the Software
and may be amended only in writing signed by both parties, except that Motorola may
modify this Agreement as necessary to comply with applicable laws.
Third party software
The software may contain one or more items of Third-Party Software supplied by other
third-party suppliers. The terms of this Agreement govern your use of any Third-Party
Software UNLESS A SEPARATE THIRD-PARTY SOFTWARE LICENSE IS INCLUDED, IN
WHICH CASE YOUR USE OF THE THIRD-PARTY SOFTWARE WILL THEN BE GOVERNED
BY THE SEPARATE THIRD-PARTY LICENSE.
phn-2182_003v004 (Oct 2011)
Motorola Solutions, Inc. end user license agreement
UNDER DEVELOPMENT
3-7